408 related articles for article (PubMed ID: 25042637)
41. Phytoglycogen Encapsulation of Lanthanide-Based Nanoparticles as an Optical Imaging Platform with Therapeutic Potential.
Rodrigues EM; Calvert ND; Crawford JC; Liu N; Shuhendler AJ; Hemmer E
Small; 2022 Jun; 18(24):e2107130. PubMed ID: 35560500
[TBL] [Abstract][Full Text] [Related]
42. Emerging NIR light-responsive delivery systems based on lanthanide-doped upconverting nanoparticles.
Le XT; Youn YS
Arch Pharm Res; 2020 Jan; 43(1):134-152. PubMed ID: 31981073
[TBL] [Abstract][Full Text] [Related]
43. Radioisotope post-labeling upconversion nanophosphors for in vivo quantitative tracking.
Sun Y; Liu Q; Peng J; Feng W; Zhang Y; Yang P; Li F
Biomaterials; 2013 Mar; 34(9):2289-95. PubMed ID: 23274071
[TBL] [Abstract][Full Text] [Related]
44. Fabricating upconversion fluorescent nanoparticles modified substrate for dynamical control of cancer cells and pathogenic bacteria.
Li H; Chen Q; Zhao J; Urmila K
J Biophotonics; 2017 Aug; 10(8):1034-1042. PubMed ID: 27600769
[TBL] [Abstract][Full Text] [Related]
45. Triple-functional core-shell structured upconversion luminescent nanoparticles covalently grafted with photosensitizer for luminescent, magnetic resonance imaging and photodynamic therapy in vitro.
Qiao XF; Zhou JC; Xiao JW; Wang YF; Sun LD; Yan CH
Nanoscale; 2012 Aug; 4(15):4611-23. PubMed ID: 22706800
[TBL] [Abstract][Full Text] [Related]
46. Near-Infrared-Triggered Upconverting Nanoparticles for Biomedicine Applications.
Mahata MK; De R; Lee KT
Biomedicines; 2021 Jun; 9(7):. PubMed ID: 34210059
[TBL] [Abstract][Full Text] [Related]
47. Lanthanide-doped upconverting luminescent nanoparticle platforms for optical imaging-guided drug delivery and therapy.
Shen J; Zhao L; Han G
Adv Drug Deliv Rev; 2013 May; 65(5):744-55. PubMed ID: 22626980
[TBL] [Abstract][Full Text] [Related]
48. An 800 nm driven NaErF
Li Q; Li X; Zhang L; Zuo J; Zhang Y; Liu X; Tu L; Xue B; Chang Y; Kong X
Nanoscale; 2018 Jul; 10(26):12356-12363. PubMed ID: 29694473
[TBL] [Abstract][Full Text] [Related]
49. Lanthanide-Doped Upconversion Nanoparticles: Exploring A Treasure Trove of NIR-Mediated Emerging Applications.
Malhotra K; Hrovat D; Kumar B; Qu G; Houten JV; Ahmed R; Piunno PAE; Gunning PT; Krull UJ
ACS Appl Mater Interfaces; 2023 Jan; 15(2):2499-2528. PubMed ID: 36602515
[TBL] [Abstract][Full Text] [Related]
50. Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy.
Wang C; Cheng L; Liu Z
Biomaterials; 2011 Feb; 32(4):1110-20. PubMed ID: 20965564
[TBL] [Abstract][Full Text] [Related]
51. Near-infrared-triggered anticancer drug release from upconverting nanoparticles.
Fedoryshin LL; Tavares AJ; Petryayeva E; Doughan S; Krull UJ
ACS Appl Mater Interfaces; 2014 Aug; 6(16):13600-6. PubMed ID: 25090028
[TBL] [Abstract][Full Text] [Related]
52. Multicolor output and shape controlled synthesis of lanthanide-ion doped fluorides upconversion nanoparticles.
Niu W; Wu S; Zhang S; Li J; Li L
Dalton Trans; 2011 Apr; 40(13):3305-14. PubMed ID: 21359354
[TBL] [Abstract][Full Text] [Related]
53. Lab on upconversion nanoparticles: optical properties and applications engineering via designed nanostructure.
Li X; Zhang F; Zhao D
Chem Soc Rev; 2015 Mar; 44(6):1346-78. PubMed ID: 25052250
[TBL] [Abstract][Full Text] [Related]
54. Nano-bio interactions of upconversion nanoparticles at subcellular level: biodistribution and cytotoxicity.
Zajdel K; Bartczak D; Frontczak-Baniewicz M; Ramsay DA; Kowalik P; Sobczak K; Kamińska I; Wojciechowski T; Minikayev R; Goenaga-Infante H; Sikora B
Nanomedicine (Lond); 2023 Feb; 18(3):233-258. PubMed ID: 37078419
[No Abstract] [Full Text] [Related]
55. Enhanced red emission from GdF3:Yb3+,Er3+ upconversion nanocrystals by Li+ doping and their application for bioimaging.
Yin W; Zhao L; Zhou L; Gu Z; Liu X; Tian G; Jin S; Yan L; Ren W; Xing G; Zhao Y
Chemistry; 2012 Jul; 18(30):9239-45. PubMed ID: 22729946
[TBL] [Abstract][Full Text] [Related]
56. Silica coated upconversion nanoparticles: a versatile platform for the development of efficient theranostics.
Liu JN; Bu WB; Shi JL
Acc Chem Res; 2015 Jul; 48(7):1797-805. PubMed ID: 26057000
[TBL] [Abstract][Full Text] [Related]
57. Fabrication of versatile cyclodextrin-functionalized upconversion luminescence nanoplatform for biomedical imaging.
Ma C; Bian T; Yang S; Liu C; Zhang T; Yang J; Li Y; Li J; Yang R; Tan W
Anal Chem; 2014 Jul; 86(13):6508-15. PubMed ID: 24848775
[TBL] [Abstract][Full Text] [Related]
58. Dual modal in vivo imaging using upconversion luminescence and enhanced computed tomography properties.
Zhang G; Liu Y; Yuan Q; Zong C; Liu J; Lu L
Nanoscale; 2011 Oct; 3(10):4365-71. PubMed ID: 21904751
[TBL] [Abstract][Full Text] [Related]
59. Multifunctional Nano-Bioprobes Based on Rattle-Structured Upconverting Luminescent Nanoparticles.
Lu S; Tu D; Hu P; Xu J; Li R; Wang M; Chen Z; Huang M; Chen X
Angew Chem Int Ed Engl; 2015 Jun; 54(27):7915-9. PubMed ID: 26013002
[TBL] [Abstract][Full Text] [Related]
60. Recent advances in design and fabrication of upconversion nanoparticles and their safe theranostic applications.
Gu Z; Yan L; Tian G; Li S; Chai Z; Zhao Y
Adv Mater; 2013 Jul; 25(28):3758-79. PubMed ID: 23813588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
